The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA Peptide Update: Category 2 Removals Explained The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and AP's BPC 157 peptide warning skips every doctor who disagrees Seattle Red